These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10653054)

  • 1. Influence of higher than conventional doses of oxitropium bromide on formoterol-induced bronchodilation in COPD.
    Cazzola M; Matera MG; Di Perna E; Califano C; D'Amato M; Mazzarella G
    Respir Med; 1999 Dec; 93(12):909-11. PubMed ID: 10653054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD.
    Cazzola M; Di Perna F; Noschese P; Vinciguerra A; Calderaro F; Girbino G; Matera MG
    Eur Respir J; 1998 Jun; 11(6):1337-41. PubMed ID: 9657576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effect of pretreatment with single conventional dose of salmeterol on dose-response curve to oxitropium bromide in chronic obstructive pulmonary disease.
    Cazzola M; Di Perna F; Centanni S; Califano C; Donner CF; D'Amato M; D'Amato G
    Thorax; 1999 Dec; 54(12):1083-6. PubMed ID: 10567627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incremental benefit of adding oxitropium bromide to formoterol in patients with stable COPD.
    Cazzola M; Di Perna F; Califano C; Vinciguerra A; D'Amato M
    Pulm Pharmacol Ther; 1999; 12(4):267-71. PubMed ID: 10501652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Izumi T
    Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of higher than standard doses of salbutamol and ipratropium on tiotropium-induced bronchodilation in patients with stable COPD.
    Cazzola M; Santus P; D'Adda A; Pizzolato S; Di Marco F; Centanni S
    Pulm Pharmacol Ther; 2009 Jun; 22(3):177-82. PubMed ID: 19038356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease.
    Cazzola M; Matera MG; Di Perna F; Calderaro F; Califano C; Vinciguerra A
    Respir Med; 1998 Feb; 92(2):354-7. PubMed ID: 9616538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxitropium bromide improves exercise performance in patients with COPD.
    Ikeda A; Nishimura K; Koyama H; Sugiura N; Izumi T
    Chest; 1994 Dec; 106(6):1740-5. PubMed ID: 7988193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response study.
    Cazzola M; Matera MG; Santangelo G; Vinciguerra A; Rossi F; D'Amato G
    Respir Med; 1995 May; 89(5):357-62. PubMed ID: 7638371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests.
    Oga T; Nishimura K; Tsukino M; Hajiro T; Ikeda A; Izumi T
    Am J Respir Crit Care Med; 2000 Jun; 161(6):1897-901. PubMed ID: 10852763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchodilator response to formoterol after regular tiotropium or to tiotropium after regular formoterol in COPD patients.
    Cazzola M; Noschese P; Salzillo A; De Giglio C; D'Amato G; Matera MG
    Respir Med; 2005 May; 99(5):524-8. PubMed ID: 15823447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxitropium bromide. Dose-response and time-response study of a new anticholinergic bronchodilator drug.
    Frith PA; Jenner B; Dangerfield R; Atkinson J; Drennan C
    Chest; 1986 Feb; 89(2):249-53. PubMed ID: 3510822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled oxitropium bromide is currently used as the first-line therapy of patients with chronic pulmonary disease in Japan.
    Teramoto S; Ouchi Y
    Eur Respir J; 1999 Feb; 13(2):473-5. PubMed ID: 10065703
    [No Abstract]   [Full Text] [Related]  

  • 14. A single high dose of formoterol is as effective as the same dose administered in a cumulative manner in patients with acute exacerbation of COPD.
    Cazzola M; Santus P; Matera MG; Carlucci P; Belloli E; Di Marco F; Centanni S
    Respir Med; 2003 May; 97(5):458-62. PubMed ID: 12735660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid onset of bronchodilation in COPD: a placebo-controlled study comparing formoterol (Foradil Aerolizer) with salbutamol (Ventodisk).
    Benhamou D; Cuvelier A; Muir JF; Leclerc V; Le Gros V; Kottakis J; Bourdeix I
    Respir Med; 2001 Oct; 95(10):817-21. PubMed ID: 11601748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency.
    Palmqvist M; Persson G; Lazer L; Rosenborg J; Larsson P; Lötvall J
    Eur Respir J; 1997 Nov; 10(11):2484-9. PubMed ID: 9426083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bronchodilator response to formoterol Turbuhaler in patients with COPD under regular treatment with formoterol Turbuhaler.
    Cazzola M; Matera MG; D'Amato M; Califano C; Sanduzzi A; Vatrella A; D'Amato G
    Pulm Pharmacol Ther; 2003; 16(2):105-9. PubMed ID: 12670779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formoterol Turbuhaler for as-needed therapy in patients with mild acute exacerbations of COPD.
    Cazzola M; Di Perna F; D'Amato M; Califano C; Matera MG; D'Amato G
    Respir Med; 2001 Nov; 95(11):917-21. PubMed ID: 11716207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchodilator response to albuterol after regular formoterol and effects of acute corticosteroid administration.
    Lipworth BJ; Aziz I
    Chest; 2000 Jan; 117(1):156-62. PubMed ID: 10631214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchodilatory responses to formoterol, ipratropium, and their combination in patients with stable COPD.
    Sichletidis L; Kottakis J; Marcou S; Constantinidis TC; Antoniades A
    Int J Clin Pract; 1999; 53(3):185-8. PubMed ID: 10665129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.